title: Analysis of FcgammaRIIA cytoplasmic tail requirements in signaling for serotonin secretion: evidence for an ITAM-dependent, PI3K-dependent pathway.
abstract: The human Fc receptor, FcgammaRIIA, is known to mediate phagocytosis and endocytosis, yet the greatest numbers of these receptors are expressed on the surface of non-phagocytic platelets, where they are involved in serotonin secretion. FcgammaRIIA harbours three tyrosine (Y) residues within its cytoplasmic domain. Y1 is upstream of both Y2 and Y3, which are contained within an immunoreceptor tyrosine-based activation motif (ITAM), required for many signaling events. We have demonstrated that the two ITAM tyrosines are required for phagocytic signaling and that mutation of a single ITAM tyrosine decreases but does not abolish phagocytic signaling. Furthermore, we have identified that the YMTL motif is required for endocytosis. These observations suggest that FcgammaRIIA utilizes different sequences for various signaling events. Therefore, we investigated the sequence requirements for another important FcgammaRIIA-mediated signaling event, serotonin secretion, using Rat Basophilic Leukemia (RBL-2H3) cells transfected with wildtype (WT) FcgammaRIIA or mutant FcgammaRIIA. Stimulation of cells expressing WT FcgammaRIIA induced release of serotonin at a level 7-fold greater than that in nonstimulated WT FcgammaRIIA-transfected cells or nontransfected RBL cells. Mutation of either ITAM tyrosine (Y2 or Y3) to phenylalanine was sufficient to abolish serotonin secretion. Further, while inhibition of Syk with piceatannol blocked phagocytosis as expected, it did not inhibit serotonin secretion. Additionally, inhibition of phosphoinositol-3-kinase (PI3K) with wortmannin only had a partial effect on serotonin signaling, despite the fact that the concentrations used completely abolished phagocytic signaling. These data suggest that the requirements for serotonin secretion differ from those for phagocytosis mediated by FcgammaRIIA.
authors.affiliation: Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
authors.forename: A B
authors.initials: AB
authors.lastname: Daniels
authors.forename: R G
authors.initials: RG
authors.lastname: Worth
authors.forename: R J
authors.initials: RJ
authors.lastname: Dickstein
authors.forename: J S
authors.initials: JS
authors.lastname: Dickstein
authors.forename: T-H
authors.initials: TH
authors.lastname: Kim-Han
authors.forename: M-K
authors.initials: MK
authors.lastname: Kim
authors.forename: A D
authors.initials: AD
authors.lastname: Schreiber
mesh_terms: D000818:Animals; D001792:Blood Platelets / Q000378:metabolism*; D045744:Cell Line, Tumor; D003593:Cytoplasm / Q000378:metabolism; D010587:Phagocytosis / Q000502:physiology; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D051381:Rats; D017452:Receptors, IgG / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D014162:Transfection
chemical_list: C080568:Fc gamma receptor IIA; D017452:Receptors, IgG; D012701:Serotonin; D019869:Phosphatidylinositol 3-Kinases; D011505:Protein-Tyrosine Kinases
references.citation: Exp Hematol. 2006 Nov;34(11):1490-5
references.pmid: 17046568
references.citation: J Immunol. 1992 Aug 15;149(4):1365-73
references.pmid: 1386863
references.citation: Immunol Lett. 1995 Jan;44(2-3):133-8
references.pmid: 7797242
references.citation: EMBO J. 2002 Feb 1;21(3):251-8
references.pmid: 11823418
references.citation: FEBS Lett. 1997 Jan 2;400(1):11-4
references.pmid: 9000504
references.citation: Blood. 2003 Nov 15;102(10):3637-45
references.pmid: 12893767
references.citation: Blood. 1995 Dec 15;86(12):4389-99
references.pmid: 8541526
references.citation: Blood. 1994 Sep 15;84(6):1753-9
references.pmid: 7521687
references.citation: J Biol Chem. 1999 Jan 22;274(4):1898-904
references.pmid: 9890943
references.citation: Blood. 2000 Nov 15;96(10):3439-46
references.pmid: 11071639
references.citation: J Biol Chem. 1998 Sep 18;273(38):24314-21
references.pmid: 9733717
references.citation: Blood. 2008 Oct 1;112(7):2780-6
references.pmid: 18641368
references.citation: J Clin Invest. 1991 Nov;88(5):1766-71
references.pmid: 1834702
references.citation: Atherosclerosis. 2006 Mar;185(1):173-6
references.pmid: 16005880
references.citation: J Immunol. 1994 Jan 1;152(1):270-9
references.pmid: 7504712
references.citation: J Biol Chem. 2003 Jan 31;278(5):3331-8
references.pmid: 12424246
references.citation: Blood. 1998 Mar 1;91(5):1762-8
references.pmid: 9473244
references.citation: Biochim Biophys Acta. 1999 Oct 13;1452(1):46-59
references.pmid: 10525159
references.citation: J Biol Chem. 1999 Nov 12;274(46):32662-6
references.pmid: 10551821
references.citation: Exp Hematol. 1999 May;27(5):875-84
references.pmid: 10340404
references.citation: J Immunol. 1999 Dec 15;163(12):6785-93
references.pmid: 10586078
references.citation: Annu Rev Immunol. 1997;15:203-34
references.pmid: 9143687
references.citation: J Immunol. 1999 Dec 1;163(11):6123-31
references.pmid: 10570302
references.citation: EMBO J. 1994 Jul 1;13(13):2963-9
references.pmid: 8039492
references.citation: J Biol Chem. 1994 Nov 25;269(47):29697-703
references.pmid: 7961959
references.citation: J Cell Biol. 1994 Aug;126(4):991-1004
references.pmid: 8051216
references.citation: J Immunol. 2001 Jul 15;167(2):844-54
references.pmid: 11441091